Renal cell carcinoma escapes NK cell‐mediated immune surveillance through the downregulation of DNAM‐1-Reference-Cited by-同舟云学术

Renal cell carcinoma escapes NK cell‐mediated immune surveillance through the downregulation of DNAM‐1

Published:2023-06-14 Issue:7 Volume:43 Page:855-859
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Tong Le¹,Kremer Veronika¹,Neo Shi Yong¹²,Liu Yaxuan¹,Chen Yi¹³,Wagner Arnika Kathleen⁴,Yang Ying¹,Chen Ziqing¹⁵,Seitz Christina⁶,Tobin Nicholas Patrick¹,Ligtenberg Maarten Alexander¹⁷,Alici Evren⁴,Chen Xinsong¹^ORCID,Haglund Felix¹,Seliger Barbara⁸⁹,Harmenberg Ulrika¹,Colón Eugenia¹⁰,Plogell Ann‐Helén Scherman¹¹,Liu Lisa Lei¹,Lundqvist Andreas¹^ORCID

Affiliation:

1. Department of Oncology‐Pathology Karolinska Institutet Stockholm Sweden

2. Singapore Immunology Network Agency for Science Technology and Research Singapore Singapore

3. Department of Medicine Columbia University Irving Medical Center New York USA

4. Department of Medicine Huddinge Karolinska Institutet Stockholm Sweden

5. Department of Molecular Biology Princeton University New Jersey USA

6. Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

7. Department of Molecular Oncology The Netherlands Cancer Institute Amsterdam Netherlands

8. Institute for Medical Immunology Martin‐Luther University Halle‐Wittenberg Halle Germany

9. Institute of Translational Immunology Medical School Theodor Fontane Brandenburg an der Havel 14770 and Fraunhofer Institute for Cell Therapy and Immunology Leipzig Germany

10. Department of Women's and Children's Health Karolinska Institutet and S:t Göran's Hospital‐Unilabs Stockholm Sweden

11. Department of Urology Stockholm South General Hospital Stockholm Sweden

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12446

Reference10 articles.

1. Escape of tumor cells from the NK cell cytotoxic activity

2. CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

3. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy

4. Immune signature of tumor infiltrating immune cells in renal cancer

5. IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma